Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
- SFA_dividend_26062026_EN_espi.pdfNotification on the terms and conditions for distribution of the dividend voted at the Annual General Meeting of Shareholders of Sopharma AD held on June 26, 2026
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 201 | / | 2026 | ||||||||
| Date of issue: | 2026-06-26 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Notification on the terms and conditions for distribution of the dividend voted at the Annual General Meeting of Shareholders of Sopharma AD held on June 26, 2026 | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 56. 1. 2 of Act on Public Offering | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sofia, Bulgaria, June 26, 2026 – In accordance with the requirements of art. 115c, para. 4 of LPOS “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies all shareholders of the Company about the decision of the AGM of “Sopharma” AD that took place on June 26, 2026 regarding the type and amount of the voted dividend for 2025, the terms and conditions for its payment: The General Meeting of Shareholders approved the proposal of the Board of Directors to distribute a gross dividend to shareholders in the amount of EUR 0.052 /5.2 euro cents/ per share. The right to receive dividends is granted to persons registered in the register of „Central Depository“ AD as shareholders on the 14th day after the day of the General Meeting at which the annual financial report for 2025 was adopted and a decision was made to pay a dividend, namely July 10, 2026 (dividend record date); respectively, ex-dividend date – July 9, 2026 (ex-dividend date); starting date for dividend payment – August 24, 2026. In accordance with the Regulations of "Central Depository" AD, the dividend will be paid as follows: for shareholders with open client accounts with investment intermediaries - through the respective investment intermediary; for shareholders without accounts with investment intermediaries - through the branches of "Eurobank Bulgaria" AD (Post Bank) in the country. We draw the attention of all foreign shareholders who wish to provide original documents for avoiding double taxation to do so no later than August 7, 2026 at the address: Sofia 1756, 5 “Lachezar Stanchev” Str., Tower A, floor 11, for the attention of the Investor Relations Department (contacts for additional information ir@sopharma.bg / +359 2 8134 319). | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| SFA_dividend_26062026_EN_espi.pdf SFA_dividend_26062026_EN_espi.pdf | Notification on the terms and conditions for distribution of the dividend voted at the Annual General Meeting of Shareholders of Sopharma AD held on June 26, 2026 | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2026-06-26 | Ognian Ivanov Donev | Executive Director | |||
